Gadoxetic acid: Difference between revisions
(Created page with "<div style="float: right;"> thumb|none|400px|This image is provided by the National Library of Medicine.</div> __NOTOC__ {{SI}} {{CMG}} ==Overvi...") |
No edit summary |
||
Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Gadoxetic acid.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Gadoxetic acid.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Gadoxetic acid''' is a | '''Gadoxetic acid''' is a gadolinium-based MRI contrast agent. Its salt, '''gadoxetate disodium''', is marketed as '''Primovist''' in Europe and '''Eovist''' in the United States by Bayer HealthCare Pharmaceuticals.<ref name="bayer">{{cite web |url=http://imaging.bayerhealthcare.com/html/eovist/index.html |title=Eovist - Homepage |work= |accessdate=2009-03-22}}</ref> | ||
==References== | ==References== | ||
Line 16: | Line 12: | ||
{{Contrast media}} | {{Contrast media}} | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Revision as of 19:34, 7 April 2015
WikiDoc Resources for Gadoxetic acid |
Articles |
---|
Most recent articles on Gadoxetic acid Most cited articles on Gadoxetic acid |
Media |
Powerpoint slides on Gadoxetic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Gadoxetic acid at Clinical Trials.gov Trial results on Gadoxetic acid Clinical Trials on Gadoxetic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Gadoxetic acid NICE Guidance on Gadoxetic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Gadoxetic acid Discussion groups on Gadoxetic acid Patient Handouts on Gadoxetic acid Directions to Hospitals Treating Gadoxetic acid Risk calculators and risk factors for Gadoxetic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Gadoxetic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.[1]
References
- ↑ "Eovist - Homepage". Retrieved 2009-03-22.